Skip to Content

Cases & Investigations
Cornerstone Therapeutics Inc. Stockholder Litigation

Type: Notable Cases

Case Number: 8922

Court: Delaware Chancery Court

Settlement Amount: $17,900,000

Wolf Popper was appointed as a lead counsel to represent the class of Cornerstone Therapeutics Inc. stockholders in a case arising from Cornerstone’s acquisition by its majority shareholder: Chiesi Farmaceutici SpA., which had already owned a 65 percent stake.  In the suit, Cornerstone and individual directors were accused of selling the company at an unfair price in breach of their fiduciary duties.
 

Contact Instructions

You may share a link to this page on any of the sites listed below or send link via email:

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Notice.

Accept & Hide Message